---
title: "12 Health Care Stocks Moving In Monday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299686795.md"
description: "During Monday's after-market session, several healthcare stocks experienced significant volatility. Gainers included Milestone Scientific (+11.8%), Evotec (+8.44%), and Universe Pharmaceuticals (+6.46%). Conversely, losers featured CytoMed Therapeutics (-15.4%), Beyond Air (-7.35%), and Quest Diagnostics (-6.9%). These movements reflect investor reactions to recent earnings reports and market sentiment within the sector."
datetime: "2026-09-21T21:06:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299686795.md)
  - [en](https://longbridge.com/en/news/299686795.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299686795.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's After-Market Session

### Gainers

-   **Milestone Scientific** (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's after-market session. The company's market cap stands at $36.9 million.
-   **Evotec** (NASDAQ:EVO) stock rose 8.44% to $1.67. The company's market cap stands at $568.6 million.
-   **Universe Pharmaceuticals** (NASDAQ:UPC) stock rose 6.46% to $4.94. The market value of their outstanding shares is at $24.4 million.
-   **NovaBridge Biosciences** (NASDAQ:NBP) shares increased by 6.21% to $1.71. The company's market cap stands at $184.4 million.
-   **AnaptysBio** (NASDAQ:ANAB) shares increased by 5.62% to $58.01. The market value of their outstanding shares is at $1.6 billion. As per the press release, Q2 earnings came out today.
-   **Creative Medical Tech** (NASDAQ:CELZ) shares moved upwards by 5.47% to $1.06. The market value of their outstanding shares is at $6.3 million.

### Losers

-   **CytoMed Therapeutics** (NASDAQ:GDTC) shares declined by 15.4% to $0.82 during Monday's after-market session. The company's market cap stands at $11.5 million.
-   **Beyond Air** (NASDAQ:XAIR) stock decreased by 7.35% to $2.9. The market value of their outstanding shares is at $3.0 million.
-   **Quest Diagnostics** (NYSE:DGX) shares decreased by 6.9% to $228.0. The market value of their outstanding shares is at $27.2 billion.
-   **Mira Pharmaceuticals** (NASDAQ:MIRA) shares declined by 6.69% to $0.82. The company's market cap stands at $34.9 million.
-   **Silexion Therapeutics** (NASDAQ:SLXN) stock declined by 6.07% to $0.51. The company's market cap stands at $2.4 million.
-   **iTonic Holdings** (NASDAQ:ITOC) stock fell 6.07% to $0.31. The company's market cap stands at $5.4 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [MLSS.US](https://longbridge.com/en/quote/MLSS.US.md)
- [XAIR.US](https://longbridge.com/en/quote/XAIR.US.md)
- [GDTC.US](https://longbridge.com/en/quote/GDTC.US.md)
- [DGX.US](https://longbridge.com/en/quote/DGX.US.md)
- [EVO.US](https://longbridge.com/en/quote/EVO.US.md)
- [UPC.US](https://longbridge.com/en/quote/UPC.US.md)
- [EVT.DE](https://longbridge.com/en/quote/EVT.DE.md)
- [NBP.US](https://longbridge.com/en/quote/NBP.US.md)
- [ANAB.US](https://longbridge.com/en/quote/ANAB.US.md)
- [CELZ.US](https://longbridge.com/en/quote/CELZ.US.md)
- [MIRA.US](https://longbridge.com/en/quote/MIRA.US.md)
- [SLXN.US](https://longbridge.com/en/quote/SLXN.US.md)
- [ITOC.US](https://longbridge.com/en/quote/ITOC.US.md)
- [SLXNW.US](https://longbridge.com/en/quote/SLXNW.US.md)

## Related News & Research

- [Quest Diagnostics Awards Chief Commercial Officer Mark Delaney 2,615 Restricted Stock Units](https://longbridge.com/en/news/304547381.md)
- [Payden & Rygel Sells 30,400 Shares of Quest Diagnostics Incorporated $DGX](https://longbridge.com/en/news/303828264.md)
- [Quest Diagnostics (DGX) Raised Guidance, Has The Rally Already Priced It In?](https://longbridge.com/en/news/303752119.md)
- [JPMorgan Chase increases total voting rights in Evotec to 6.54% from 5.64%](https://longbridge.com/en/news/303550315.md)
- [Goldman Sachs cuts total voting rights in Evotec to 13.51% from 13.56%](https://longbridge.com/en/news/303419491.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**